Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents

European Radiology

Volumn 20, Issue 3, 2010, Pages 595-603

  Hoppe, Hanno ^a   Spagnuolo, Sara ^a   Froehlich, Johannes M ^a   Nievergelt, Helga ^a   Dinkel, Hans Peter ^b   Gretener, Silvia ^c   Thoeny, Harriet C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Hospital Landshut   (Germany)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiography; Contrast media; Gadolinium; NSF; Renal insufficiency

Indexed keywords

CREATININE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM;

ABDOMINAL AORTA ANEURYSM; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ANGINA PECTORIS; AORTA STENOSIS; ARTERIOSCLEROSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; COXITIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GASTRECTOMY BILLROTH I; GLOMERULUS FILTRATION RATE; HEART DISEASE; HUMAN; KIDNEY FAILURE; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SKIN BIOPSY; CHEMICALLY INDUCED DISORDER; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 77952312775     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1586-0     Document Type: Article

References (22)

1. Spinosa DJ, Angle JF, Hagspiel KD, Kern JA, Hartwell GD, Matsumoto AH (2000) Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency. J Vasc Interv Radiol 11:35-43
2. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, McGraw JK, Ayers C (1999) Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment. Radiology 210:663-672
3. Thomsen HS, Almen T, Morcos SK (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600-2605
4. Spinosa DJ, Matsumoto AH, Angle JF, Hagspiel KD, Cage D, Bissonette EA et al (2001) Safety of CO(2)- and gadodiamide- enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency. AJR Am J Roentgenol 176:1305-1311
5. Cowper SE (2005) Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 46:763-765
6. Galan A, Cowper SE, Bucala R (2006) Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol 18:614-617
7. Gibson SE, Farver CF, Prayson RA (2006) Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature. Arch Pathol Lab Med 130:209-212
8. Grobner T (2006) Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108
9. High WA, Ayers RA, Chandler J, Zito G, Cowper SE (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21-26
10. Thomsen HS, Marckmann P, Logager VB (2007) Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 7:130-137
11. Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS (2003) Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 38:313-318
12. Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW et al (2007) Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243:148-157
13. Hope TA, Herfkens RJ, Denianke KS, Leboit PE, Hung YY, Weil E (2009) Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol. doi:10.1097/RLI.0- b013e31819343ba
14. Janus N, Launay-Vacher V, Karie S, Clement O, Ledneva E, Frances C et al (2009) Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study. Eur J Radiol. doi:10.1016/j. ejrad.2008.11.021
15. Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4:461-469
16. Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA (2009) Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases. Radiology 250:371-377
17. Thomsen HS, Marckmann P (2008) Extracellular Gd-CA: differences in prevalence of NSF. Eur J Radiol 66:180-183
18. Thomsen HS (2007) ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 17:2692-2696
19. Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST et al (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168-175
20. Thakral C, Alhariri J, Abraham JL (2007) Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media Mol Imaging 2:199-205
21. Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P (2008) Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 158:273-280
22. Broome DR (2008) Nephrogenic systemic fibrosis associated with gadoliniumbased contrast agents: a summary of the medical literature reporting. Eur J Radiol 66:230-234